Simplex Trading, LLC Syros Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$0.69 - $1.21 $96 - $169	140 New	140 $0
Q1 2022 May 02, 2022	SELL	$1.02 - $3.8 $392 - $1,463	-385 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$3.26 - $4.66 $145,826 - $208,451	-44,732 Reduced 99.15%	385 $1,000
Q3 2021 Oct 28, 2021	SELL	$4.08 - $5.66 $983 - $1,364	-241 Reduced 0.53%	45,117 $255,000
Q2 2021 Aug 12, 2021	BUY	$5.01 - $7.48 $111,743 - $166,833	22,304 Added 96.75%	45,358 $247,000
Q1 2021 Apr 26, 2021	BUY	$7.19 - $14.95 $148,430 - $308,627	20,644 Added 856.6%	23,054 $172,000
Q4 2020 Feb 02, 2021	BUY	$6.66 - $14.66 $15,471 - $34,055	2,323 Added 2670.11%	2,410 $26,000
Q3 2020 Oct 14, 2020	BUY	$8.69 - $14.47 $756 - $1,258	87 New	87 $0
Q4 2019 Feb 05, 2020	SELL	$4.52 - $10.1 $2,621 - $5,858	-580 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$7.14 - $11.65 $928 - $1,514	-130 Reduced 18.31%	580 $6,000
Q2 2019 Jul 26, 2019	BUY	$5.5 - $9.75 $1,050 - $1,862	191 Added 36.8%	710 $6,000
Q1 2019 Apr 18, 2019	SELL	$5.51 - $9.59 $3,024 - $5,264	-549 Reduced 51.4%	519 $0
Q4 2018 Jan 16, 2019	SELL	$5.55 - $11.34 $2,713 - $5,545	-489 Reduced 31.41%	1,068 $5,000
Q3 2018 Oct 23, 2018	BUY	$9.74 - $12.92 $6,145 - $8,152	631 Added 68.14%	1,557 $18,000
Q2 2018 Jul 30, 2018	SELL	$10.16 - $13.65 $15,473 - $20,788	-1,523 Reduced 62.19%	926 $9,000
Q1 2018 Apr 26, 2018	SELL	$9.47 - $12.98 $88,904 - $121,856	-9,388 Reduced 79.31%	2,449 $31,000
Q4 2017 Jan 10, 2018	BUY	$8.45 - $17.48 $100,022 - $206,910	11,837	11,837 $115,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.86M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.